Kirton, L., Apps, J., Lawson, A. et al. (16 more authors) (2024) CTNI-16. Monogerm, a novel proof-of-principle Bayesian phase II trial design of carboplatin or vinblastine monotherapy induction prior to radiotherapy for intracranial germinoma. In: 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, 21-24 Nov 2024, Houston, Texas.
Metadata
Item Type: | Conference or Workshop Item |
---|---|
Authors/Creators: |
|
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology |
Funding Information: | Funder Grant number NIHR National Inst Health Research TYA CAN COHORT STY G569 |
Depositing User: | Symplectic Publications |
Date Deposited: | 14 Jan 2025 11:13 |
Last Modified: | 14 Jan 2025 11:14 |
Published Version: | https://academic.oup.com/neuro-oncology/article/26... |
Status: | Published |
Publisher: | Oxford University Press (OUP) |
Identification Number: | 10.1093/neuonc/noae165.0383 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:221759 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online